Novartis strengthens executive committee further

Novartis this week announced changes to its senior leadership team to support the implementation of its strategic priorities. These changes include the appointment of Shannon Klinger in the elevated and expanded role of chief ethics, risk, and compliance officer, effective April 1.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.